NEUCA S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 895 PLN | -0.67% |
|
+1.47% | -3.24% |
| Mar. 23 | NEUCA S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | NEUCA S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
Business Summary
Number of employees: 4,633
Sales per Business
| PLN in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Wholesale Distribution of Medicines
92.3
%
| 10,679 | 95.1 % | 10,903 | 92.3 % | +2.09% |
Clinical Trials
3.4
%
| 194 | 1.7 % | 403 | 3.4 % | +107.93% |
Medical Operator
2.3
%
| 197 | 1.8 % | 272 | 2.3 % | +37.92% |
Insurance Activities
1.1
%
| 105 | 0.9 % | 135 | 1.1 % | +28.71% |
Manufacturer of Pharmaceuticals
0.9
%
| 58 | 0.5 % | 100 | 0.9 % | +74.41% |
Sales per region
| PLN in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Poland
100.0
%
| 11,233 | 100.0 % | 11,813 | 100.0 % | +5.16% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Piotr Sucharski
CEO | Chief Executive Officer | - | 00-12-31 |
| Founder | - | 89-12-31 | |
Grzegorz Dzik
DFI | Director of Finance/CFO | - | 10-07-31 |
| Chief Operating Officer | - | 21-03-18 | |
Kamila Mazur
IRC | Investor Relations Contact | - | - |
| Corporate Officer/Principal | - | - | |
Roman Dudzik
PRN | Corporate Officer/Principal | - | 22-10-31 |
Tomasz Dabrowski
PRN | Corporate Officer/Principal | - | 14-08-31 |
| Corporate Officer/Principal | 43 | 21-12-31 | |
Joanna Majdan
HRO | Human Resources Officer | - | - |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Founder | - | 89-12-31 | |
| Director/Board Member | 72 | 09-06-15 | |
| Founder | - | 89-12-31 | |
Piotr Borowski
BRD | Director/Board Member | 57 | 17-10-26 |
| Director/Board Member | - | 20-11-11 | |
Bozena Sliwa
BRD | Director/Board Member | - | 11-06-27 |
Jolanta Kloc
BRD | Director/Board Member | - | 18-08-13 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 4,428,824 | 1,512,277 ( 34.15 %) | 20,005 ( 0.4517 %) | 34.15 % |
Holdings
| Name | Equities | % | Valuation |
|---|---|---|---|
NEUCA S.A. 2.57% | 115,005 | 2.57% | 25,724,898 $ |
Company contact information
Group companies
| Name | Category and Sector |
|---|---|
Pretium Farm SP zoo
| |
Neuca Med Sp zoo
 Neuca Med Sp zoo Hospital/Nursing ManagementHealth Services Neuca Med Sp zoo operates general medical practice clinic. The company was founded in 2013 and is headquartered in Torun, Poland. |
Hospital/Nursing Management
|
Exom Group Srl Start-Up Innovativa
 Exom Group Srl Start-Up Innovativa Miscellaneous Commercial ServicesCommercial Services Exom Group Srl Start-Up Innovativa is a clinical research organization that specializes in modernizing clinical trials through the use of digital solutions. The private company is based in Milan, Italy. The Italian company was founded in 2014 and the CEO is Luigi Visani. |
Miscellaneous Commercial Services
|
Sector
Sales per Business
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
901
PLN
Average target price
974.7
PLN
Spread / Average Target
+8.18%
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -2.59% | 992M | |
| +2.01% | 25.01B | |
| +6.40% | 8.16B | |
| +1.96% | 8.36B | |
| -23.25% | 7.69B | |
| +0.73% | 4.53B | |
| +21.26% | 4.47B | |
| -1.46% | 3.99B | |
| -2.34% | 3.88B | |
| +22.68% | 3.66B |
- Stock Market
- Equities
- NEU Stock
- Company NEUCA S.A.
